Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy takes on tough pancreatic cancer

NCT ID NCT04257448

First seen Sep 30, 2025 · Last updated May 19, 2026 · Updated 31 times

Summary

This study tested a new treatment plan for people with advanced pancreatic cancer that has spread. It combined chemotherapy with drugs that change how genes work and boost the immune system. The goal was to see if the combination is safe and can help control the cancer. 75 patients took part in this early-phase trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Klinikum Nürnberg

    Nuremberg, 90419, Germany

  • Ludwig-Maximilians-Universität München

    München, 81377, Germany

  • Uniklinik Köln

    Cologne, 50937, Germany

  • Universitätsklinikum Essen

    Essen, 45147, Germany

  • Universitätsklinikum Frankfurt

    Frankfurt, 60590, Germany

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, 20251, Germany

  • Universitätsklinikum Ulm

    Ulm, 89081, Germany

  • Universitätsklinikum Würzburg

    Würzburg, 97080, Germany

  • Universitätsmedizin Göttingen

    Göttingen, 37075, Germany

Conditions

Explore the condition pages connected to this study.